Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 21;9(2):e89466.
doi: 10.1371/journal.pone.0089466. eCollection 2014.

DrugScorePPI knowledge-based potentials used as scoring and objective function in protein-protein docking

Affiliations

DrugScorePPI knowledge-based potentials used as scoring and objective function in protein-protein docking

Dennis M Krüger et al. PLoS One. .

Abstract

The distance-dependent knowledge-based DrugScore(PPI) potentials, previously developed for in silico alanine scanning and hot spot prediction on given structures of protein-protein complexes, are evaluated as a scoring and objective function for the structure prediction of protein-protein complexes. When applied for ranking "unbound perturbation" ("unbound docking") decoys generated by Baker and coworkers a 4-fold (1.5-fold) enrichment of acceptable docking solutions in the top ranks compared to a random selection is found. When applied as an objective function in FRODOCK for bound protein-protein docking on 97 complexes of the ZDOCK benchmark 3.0, DrugScore(PPI)/FRODOCK finds up to 10% (15%) more high accuracy solutions in the top 1 (top 10) predictions than the original FRODOCK implementation. When used as an objective function for global unbound protein-protein docking, fair docking success rates are obtained, which improve by ∼ 2-fold to 18% (58%) for an at least acceptable solution in the top 10 (top 100) predictions when performing knowledge-driven unbound docking. This suggests that DrugScore(PPI) balances well several different types of interactions important for protein-protein recognition. The results are discussed in view of the influence of crystal packing and the type of protein-protein complex docked. Finally, a simple criterion is provided with which to estimate a priori if unbound docking with DrugScore(PPI)/FRODOCK will be successful.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Distance-dependent pair-potentials of DrugScorePPI (straight line) and DrugScore (dashed).
(A) Charged interactions between atoms of types N.pl3 and O.co2; (B) polar interactions between two atoms of type O.3; (C) aromatic interactions between two atoms of type C.ar. For reasons of comparison, the potentials were aligned to a value of zero at a distance of 5 Å.
Figure 2
Figure 2. Computed scoring values of decoys from the “unbound perturbation” dataset using DrugScorePPI.
(A) Serine protease/prosegment complex (PDB-ID 1PPE); (B) trypsin/trypsin inhibitor complex (PDB ID 1SPB). The scoring values are given as a function of the rmsd from the native structure; small rmsd values denote near native-like protein-protein configurations.
Figure 3
Figure 3. Biologically relevant protein-protein complexes and non-specific protein-protein interactions arising from crystal contacts.
The receptor (ligand) in protein-protein complexes provided in the ZDOCK benchmark 3.0 is colored in cyan (green); receptor (ligand) molecules arising from crystal contacts are colored in white (black). Docking solutions are depicted in magenta. (A) Extracellular domain of the human TGF-beta type II receptor complexed with TGF-beta3 (PDB-ID 1KTZ). The docking solution was found on rank 6 when both receptor structures were considered for the docking. (B) RAC1-GDP complexed with ligand arfaptin (PDB-ID 1I4D). The docking solution was found on rank 3 when both receptor structures were considered for the docking. (C) Human cyclophillin A complexed with the amino-terminal domain of the HIV-1 capsid (PDB-ID 1AK4). The docking solution was found on rank 4 when a set of three receptor structures were considered for the docking. (D) E. coli IIIGlc complexed with glycerol kinase (PDB-ID 1GLA). The docking solution was found on rank 1 although only the native receptor was considered for the docking.
Figure 4
Figure 4. Predictions of unbound protein-protein docking obtained with DrugScorePPI/FRODOCK on the top 10 scoring ranks.
(A) Medium accuracy complex of MT-SP1/matriptase (cyan) and bovine pancreatic trypsin inhibitor (PDB ID: 1EAW). (B) Acceptable accuracy complex of ribonuclease A (cyan) and a ribonuclease inhibitor. (PDB ID: 1DFJ). In (A) and (B) ligand configurations in the crystal complex are depicted in green, and predicted ligand configurations are colored in magenta. (C) Bound crystal complex of human H-Ras (cyan) and human SOS-1 (green) (PDB ID: 1BKD) onto which the unbound ligand (orange) was aligned. Due to a large conformational change of a loop in the interface (see black ellipse) the generation of a near-native structure failed.

Similar articles

Cited by

References

    1. Dotan-Cohen D, Letovsky S, Melkman AA, Kasif S (2009) Biological process linkage networks. PLOS One 4: e5313. - PMC - PubMed
    1. Gonzalez-Ruiz D, Gohlke H (2006) Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding. Curr Med Chem 13: 2607–2625. - PubMed
    1. Metz A, Ciglia E, Gohlke H (2012) Modulating protein-protein interactions: from structural determinants of binding to druggability prediction to application. Curr Pharm Des 18: 4630–4647. - PubMed
    1. Brinda KV, Vishveshwara S (2005) Oligomeric protein structure networks: insights into protein-protein interactions. BMC Bioinformatics 6: 296. - PMC - PubMed
    1. Ofran Y, Rost B (2007) Protein-protein interaction hotspots carved into sequences. PLOS Comput Biol 3: e119. - PMC - PubMed

Publication types

LinkOut - more resources